Mariner
ACUR

Mariner’s Acura Pharmaceuticals ACUR Stock Holding History

Mariner’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,200
Closed -$11K – 586
2015
Q2 		$11K Sell
2,200
-4,000
-65% -$16.6K ﹤0.01% 522
2015
Q1 		$24K Sell
6,200
-2,199
-26% -$7.02K ﹤0.01% 394
2014
Q4 		$19K Sell
8,399
-5
-0.1% -$14 ﹤0.01% 382
2014
Q3 		$33K Sell
8,404
-2,000
-19% -$9.39K ﹤0.01% 339
2014
Q2 		$57K Hold
10,404
– – 0.01% 339
2014
Q1 		$76K Hold
10,404
– – 0.01% 322
2013
Q4 		$87K Buy
10,404
+5
+0% +$42 0.01% 336
2013
Q3 		$99K Hold
10,399
– – 0.02% 291
2013
Q2 		$98K Buy
+10,399
New +$117K 0.02% 263

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return

Mariner's ACUR Position: Q3 2015 in Review

Mariner sold out of Acura Pharmaceuticals (ACUR) in Q3 2015, closing a stake of 2,200 shares — an estimated $11K sold.

Mariner first reported a position in ACUR in Q2 2013 and held it in 9 quarters. The position peaked at $99K in Q3 2013. 22 funds tracked by Wall St. Rank hold ACUR as of Q3 2015.

  • Mariner reported no remaining Acura Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Mariner sold 2,200 Acura Pharmaceuticals shares in Q3 2015, an estimated $11K.
  • Mariner first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 9 quarters.
  • Mariner's Acura Pharmaceuticals position peaked at $99K in Q3 2013.
  • 22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q3 2015.

Based on Mariner's 13F filing for Q3 2015, filed 16 Nov 2015.